Revised Guidelines for Atrial Fibrillation

The 2006 guidelines recommend that decision making about anticoagulation therapy be based primarily on a patient’s risk for stroke.

Sponsoring Organizations: American College of Cardiology, American Heart Association, European Society of Cardiology with the European Heart Rhythm Association and the Heart Rhythm Society

Background and Purpose: Atrial fibrillation (AF) affects more than 2 million Americans and 4.5 million Europeans, and its prevalence is increasing. AF-related symptoms, hemodynamic impairment, and embolic events are associated with substantial morbidity, mortality, and financial costs. In these 2006 AF guidelines, a revision of the 2001 document, the authors provide evidence-based recommendations and algorithms for managing the different types of AF (newly discovered, recurrent paroxysmal, recurrent persistent, and permanent), as well as guidance regarding…

Reviewing Author

Mark D. Carlson, MD

Revised Guidelines for Atrial Fibrillation

Topics

Reviewing Author